| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |